51�Թ�

Older adults and people living with high-risk conditions account for the majority of deaths and hospitalizations from respiratory illnesses such as RSV, flu and COVID-19, and stand to benefit the most from effective vaccination.

RSV causes 42,000 hospitalizations a year in adults ages 50 to 64 in the U.S., as well as increased mortality rates.

Additionally, over 13 million U.S. adults ages 50 to 59 have at least one diagnosed medical condition that increases their risk for severe complications of RSV.

COVID-19 and RSV activity is low, health officials said, with positivity rates of 2.3% and 5%, respectively.

Nationwide, emergency room visits are very high for flu and moderate for RSV, according to the CDC.